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Background: Chronic Obstructive Pulmonary 
disease (COPD) is a chronic progressive 
disease with airway inflammation and 
frequent exacerbations. The main etiological 
factor for COPD amongst Sri Lankan males is 
smoking. Smoking elevates breath CO levels 
and airway inflammation elevates fraction of 
exhale nitric oxide (FeNO). However, the level 
of inflammation of airways and breath 
carboxy hemoglobin (bCO) levels of Sri 
Lankan COPD patients are unknown.  
 
Objectives:  To determine the symptom 
severity, airway inflammation and levels of 
bCO among a sample of COPD patients 
attending a chest clinic in a selected teaching 
hospital.  
 
Method: A descriptive cross sectional study 
was conducted on 145 patients diagnosed 
with COPD. Through consecutive sampling 
baseline data, and symptoms severity were 
obtained by MRC Dyspnea scale and an 
interviewer administered questionnaire. 
Airway inflammation was determined by 
breath FeNO (Bedford Inc. UK) and exhaled 
breath CO (Bedford Inc. UK). 
 
Results: 63.1% were males; low BMI was 
observed in 35.1% that which indicates poor 
nutritional status. Mean BMI of the subjects 
was 20.64 kg/m2. 53.1% were ex-smokers. 
Airway inflammation as determined by FeNO 
level was associated with smoking status 
(p<0.05). 51% had intermediate FeNO levels 
(25 – 50 ppb). Patients had high FeNO levels 
(more than 25 ppb) was taken as airway 
inflammation. Ninety three percent had low 
COHb levels (< 5 ppm), 6.1 % had 
intermediately high COHb levels (> 5 ppm). 
The mean exhaled CO level was significantly 
higher in smokers when compared to non-
smokers (<0.001). Majority (64.6%) had 
severe dyspnea level (MRC of grade 4-5) that 
indicates majority had breathlessness 
according to the MRC dyspnea scale.  
 
Conclusion: The present study confirms that 
measurements of FeNO levels can detect 
airway inflammation and bCO levels can 
determine smoking status of COPD patients. 
Poor nutritional status of COPD patients to be 
addressed by proper dietary advice and 
supplementation  
  
